Admitted local publications that cite Efficacy and Safety of Double‐Filtration Plasmapheresis Versus Efgartigimod in Generalized Myasthenia Gravis: A Single‐Center Retrospective Study.
No admitted local citation edges point to this work yet.
Cited by — Efficacy and Safety of Double‐Filtration Plasmapheresis Versus Efgartigimod in Generalized Myasthenia Gravis: A Single‐Center Retrospective Study | ResearchHub - ResearchHub
